Mental Health

LifeStance Survey Finds Nearly One-Third of Americans Use Social Media Content to Self-Diagnose Mental Health Conditions

Less Than Half of Respondents Consistently Seek Professional Guidance for Self-Diagnosed Conditions, Reinforcing the Need for Increased Access to Evidence-Based…

8 months ago

Array Behavioral Care Unites Behavioral Health Treatment Across Settings With Launch of Array CareConnect

Fragmented behavioral health care hurts both patients and providers, leading to poor outcomes and high costs while unnecessarily increasing health…

8 months ago

Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement

New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company")…

8 months ago

WELL Health Announces Results for Q4 and Full Year 2024 Reflecting Record Annual Revenue

WELL achieved annual revenue of $919.7 million in 2024, an increase of 19% compared to the prior year. Under applicable…

8 months ago

Neural Therapeutics Strengthens IP Portfolio With a Patent Application

Treatment of Major DSM-5 Disorders, Including Addiction, Depression and Anxiety, With Sub-Hallucinogenic Mescaline DosesExtraction Technology Delivering Higher Yields and Greater…

8 months ago

MYndspan Appoints Holmusk Founder and CEO Nawal Roy as Strategic Advisor

Following momentum from its Crowdcube campaign and investment from EMOTIV, MYndspan is deepening its commitment to evidence-based brain health LONDON,…

8 months ago

Weekly Recap: 15 Health Press Releases You Need to See

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including Google Cloud's commitment to AI-powered…

9 months ago

Awakn Life Sciences Provides Supplemental Disclosure in Connection with Proposed Plan of Arrangement

Toronto, Ontario--(Newsfile Corp. - April 11, 2025) - Further to its press release dated February 27, 2025 and its management…

9 months ago

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

9 months ago

Hazelden Betty Ford Foundation and Netsmart Collaborate to Enhance Behavioral Healthcare with Meaningful AI and Integrated CareFabric® Platform

OVERLAND PARK, Kan.--(BUSINESS WIRE)--#ArtificialIntelligence--The Hazelden Betty Ford Foundation, a leader in non-profit addiction and behavioral health treatment for 75 years,…

9 months ago